Literature DB >> 167683

Experimental studies concerning the possibility of a latent carrier state in bovine herpes mammillitis (BHM).

M Probert, R C Povey.   

Abstract

Adult bovines, young calves and young rats were infected with bovine herpes mammillitis (BHM) virus providing a group of BHM-recovered animals in which to investigate a possible latent carrier state. The progression of the acute infection and serological response was essentially similar to that previously reported. The effect of natural (calving, littering) and artificial (corticosteroid treatment) stress on these animals following recovery from infection was investigated, but reactivation of BHM was never detected. Long term observation of cocultures of BHM virus infected-and-recovered bovine teat dermis with bovine embryo cells failed to reveal any evidence for the induction of BHM virus replication even in those cocultures treated with mitomycin C or bromodeoxyuridine. Similarly, cocultures utilizing lumbar dorsal root ganglia from the same animals were also negative with respect to the induction of virus replication. Experiments using cytosine arabinoside indicated that an artificial in vitro latent carrier state of BHM virus could be maintained for 6 days with subsequent sporadic virus reactivation, but an attempt to maintain such a state for 12 days was unsuccessful, with no subsequent virus reactivation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167683     DOI: 10.1007/bf01320563

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  38 in total

1.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

Authors:  P Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

2.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

3.  Herpes-simplex virus from trigeminal ganglion.

Authors:  S Rodda; I Jack; D O White
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

4.  An examination of certain features of the fine structure of bovine hepres mammillitis virus by negative staining.

Authors:  E P Gibbs; C A Voyle; C R Madeley
Journal:  Res Vet Sci       Date:  1971-11       Impact factor: 2.534

5.  Production of generalised skin lesions in calves inoculated with bovine mammillitis virus.

Authors:  D A Haig
Journal:  Vet Rec       Date:  1967-03-04       Impact factor: 2.695

6.  Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide.

Authors:  G A Cole; N Nathanson
Journal:  Nature       Date:  1968-10-26       Impact factor: 49.962

7.  [Studies on the persistence of the bovine IBR-IPV virus in the semen of normally infected bulls].

Authors:  R Böttcher; R Mahler
Journal:  Dtsch Tierarztl Wochenschr       Date:  1970-09-01

8.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

9.  Herpes-like virus of the guinea pig: propagation in brain tissue of guinea pigs and mice.

Authors:  J Booss; G D Hsiung
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

10.  Cellular pathology of calves experimentally infected with bovine herpes mammillitis virus.

Authors:  A W Lepper; D A Haig; J Wilcox
Journal:  J Comp Pathol       Date:  1969-10       Impact factor: 1.311

View more
  3 in total

1.  Bovid herpesvirus 2 latency: failure to recover virus from central sensory nerve ganglia.

Authors:  G J Letchworth; L E Carmichael
Journal:  Can J Comp Med       Date:  1982-01

2.  Latent infection of cattle with bovid herpesvirus 2.

Authors:  W B Martin; F M Scott
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Reactivation in calves of Bovid herpesvirus 2 latent infection.

Authors:  G Castrucci; M Ferrari; F Frigeri; S Ranucci; V Cilli; B Tesei; L Rampichini
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.